Clinical Microbiology and Infectious Diseases

Euro Clinical Microbiology 2019

Euro Clinical Microbiology 2019

The Conference Series LLC Ltd organizes conferences around the world on all medical subjects including microbiology and its related fields. Here we are happy to invite all microbiology researchers/ industrialists/ students to join our "10th International Conference on Clinical Microbiology and Infectious Diseases" scheduled to be held in Rome, Italy during November 18-19, 2019. The Euro Clinical Microbiology 2019 is initiated by Editors of Journal of Clinical Microbiology: Open Access, Journal of Food & Industrial Microbiology: Open Access, and Journal of Plant Pathology & Microbiology: Open Access.

Details of Euro Clinical Microbiology 2019, Rome, Italy

About

Conferenceseries LLC Ltd and its subsidiaries including iMedPub Ltd and Conference Series Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Conferenceseries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", Conferenceseries LLC Ltd publishes scholarly journals in all aspects of Science, Engineering, Management and Technology journals. Conferenceseries LLC Ltd has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. Conferenceseries LLC Ltd also organizes 3000+ International conferences across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

Conference Sessions/Tracks

Track:1
Immunity & Vaccination:
Immunity-
Immunity is the balanced state of multicellular organisms having adequate biological defences to fight infection, disease, or other unwanted biological invasion, while having adequate tolerance to avoid allergy, and autoimmune diseases.

Vaccination-
 Vaccination is the administration of a vaccine to help the immune system develop protection from a disease. Vaccines contain a microorganism in a weakened or killed state, or proteins or toxins from the organism. In stimulating the body's adaptive immunity, they help prevent sickness from an infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. The effectiveness of vaccination has been widely studied and verified. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio and tetanus from much of the world.

Track:2
Epidemiology:
It is the cornerstone of public health, and shapes policy decisions and evidence-based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists’ help with study design, collection, and statistical analysis of data, amend interpretation and dissemination of results. Epidemiology has helped develop methodology used in clinical research, public health studies, and, to a lesser extent, basic research in the biological sciences.

Track:3
 Microbial Pathogenesis:
 Microbial Pathogenesis is the study of the molecular mechanisms used by microbes to cause disease in humans and animals. Bacterial, protozoan, fungal and viral pathogens have evolved a wide variety of tools to establish themselves in the host and gain nutrients, which also cause damage and disease. Other mechanisms of pathogenesis include host defences evasion. To understand the complex processes used by microbial pathogens, microbiologists employ all the tools of modern molecular biology, genetics, biochemistry and biophysics.

Track:4
Nosocomial Infection:
Nosocomial infection is an infection that is acquired in a hospital or other health care facility. To emphasize both hospital and nonhospital settings, it is sometimes instead called a health care–associated infection. Such an infection can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. Infection is spread to the susceptible patient in the clinical setting by various means.

Track:5
B2B Entrepreneur Investments Meet:
A crucial element in an accomplished entrepreneurship is self-knowledge. Euro Clinical Microbiology-2019 intends to en masse all bio entrepreneurs – de facto and budding, to construe the experiences and latest innovations and challenges in the present microbiological research. Annually, over a million start-ups are seen globally with about 5–10, being classified as high-tech/ futuristic companies, turning mind maps into business ventures is precarious and the crucial step is the  opportunity-recognition step in any given new Clinical venture creation. This contour in the entrepreneur's approach of the co-relation between invention and eventual product is then genteel moulded into a business prototype that specifies how the endeavour will gain finances or provide adequate returns to the probable stockholders. Biological science is an intricate and expeditiously changing and beseeches a characteristic knowledge to apprehend the essence of the innovation and its ambitious position in the industry. Although scientists are the founders of biotech organizations, surveys have shown that the most successful hi-tech start-ups are headed by a team of two/ three individuals with eclectic backgrounds, profuse industrial experience and a coherent market and product target at organizing. This two day inter-disciplinary conference will be eminently interactive & will en masse elites in fields of Structural Microbiology to Signalling Pathways to Novel Therapeutic Approaches. Additionally, congress meet will also have short talks and poster presentations.

Track:6
Infection Control:
Infection control is the discipline concerned with preventing nosocomial or healthcare-associated infection, a practical (rather than academic) sub-discipline of epidemiology. It is an essential, though often under recognized and under supported, part of the infrastructure of health care. Infection control and hospital epidemiology are akin to public health practice, practiced within the confines of a particular health-care delivery system rather than directed at society as a whole. Anti-infective agents include antibiotics, antibacterial, antifungals, antivirals and antiprotozoal.

Track:7
Parasitic Diseases:
A parasitic disease also known as parasitizes, is an infectious disease caused or transmitted by a parasite. Many parasites do not cause diseases as it may eventually lead to death of both organism and host. Parasitic diseases can affect practically all living organisms, including plants and mammals. The study of parasitic diseases is called parasitology.

Track:8
Fungal Diseases:
Fungal diseases are common throughout much of the natural world. In humans, fungal infections occur when an invading fungus takes over an area of the body and is too much for the immune system to handle. Fungi can live in the air, soil, water, and plants. There are also some fungi that live naturally in the human body. Like many microbes, there are helpful fungi and harmful fungi. When harmful fungi invade the body, they can be difficult to kill, as they can survive in the environment and re-infect the person trying to get better.

Track:9
Viral Infections:
A viral infection is a proliferation of a harmful virus inside the body. Viruses cannot reproduce without the assistance of a host. Viruses infect a host by introducing their genetic material into the cells and hijacking the cell's internal machinery to make more virus particles. With an active viral infection, a virus makes copies of itself and bursts the host cell (killing it) to set the newly-formed virus particles free. In other cases, virus particles “bud” off the host cell over a period of time before killing the host cell. Either way, new virus particles are then free to infect other cells. Symptoms of the viral illness occur as a result of cell damage, tissue destruction, and the associated immune response. A viral infection occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles attach to and enter susceptible cells.

Track:10
Bacterial diseases:
Bacterial diseases refer to a large variety of diseases caused by bacteria or bacterial components that affect humans, domesticated animals, wildlife, fish, and birds. Most of these diseases are contagious—that is, they can be passed from one member of a species to another member, or, in a smaller number of instances, from one species to a different species. Depending on the organism, bacterial disease can be spread in different ways. Examples include contaminated food or water, air currents, infection of an environment that is not normally inhabited by the particular bacterium, and the possession or release of toxins by the bacteria.

Track:11
Antimicrobial Agents:
Antimicrobial agents are any substances that kill or slow the growth of microbes. These substances can be derived from naturally occurring substances or can be synthetic. They are highly regulated in the United States and many other countries to ensure that the products and solutions that utilize them are safe for consumers and for the environment and ultimately provide value to the consumers.

Track:12
Antimicrobials and Chemotherapy:
Antimicrobial chemotherapy is the clinical application of antimicrobial agents to treat infectious disease.

Track:13
Disease Diagnosis and Prevention:
Disease Diagnosis –
Identification of a condition, disease, disorder, or problem by systematic analysis of the background or history, examination of the signs or symptoms, evaluation of the research or test results, and investigation of the assumed or probable causes. Effective prognosis is not possible without effective diagnosis.

Disease Prevention-
Disease prevention is a procedure through which individuals, particularly those with risk factors for a disease, are treated in order to prevent a disease from occurring. Treatment normally begins either before signs and symptoms of the disease occur, or shortly thereafter. Treatment can include patient education, lifestyle modification, and drugs.

Most people know that good hygiene, sanitation and immunizations can prevent infections. They also know if they don’t smoke, eat healthily and exercise regularly they can reduce their chances of developing diabetes or experiencing a heart attack or a stroke and that if they wear a seatbelt, don’t drink and drive or speed, they are far less likely to be injured or killed on our roads.

Track:14
Dynamics and consequences of antimicrobial resistance:
Antimicrobial resistance-
Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective. When the microorganisms become resistant to most antimicrobials they are often referred to as “superbugs”. This is a major concern because a resistant infection may kill, can spread to others, and imposes huge costs to individuals and society.

Antimicrobial resistance makes it harder to eliminate infections from the body as existing drugs become less effective. As a result, some infectious diseases are now more difficult to treat than they were just a few decades ago. As more microbes become resistant to antimicrobials, the protective value of these medicines is reduced. Overuse and misuse of antimicrobial medicines are among the factors that have contributed to the development of drug-resistant microbes.

Consequences of antimicrobial resistance-
The disease consequences of resistance should be assessed according to the morbidity and mortality rate due to antibiotic resistant organisms. It can be assumed that resistant microorganisms lead to an increase in morbidity and mortality since resistance increases the risk of inappropriate therapy. There is an increased risk that patients who do not receive appropriate treatment will have a longer course of disease or a fatal outcome; moreover, as these patients remain infectious for a longer period, morbidity and transmission of the microorganism are increased. Such increased morbidity was documented in outbreaks of diseases such as shigellosis, typhoid fever, and pneumococcal infections.

Dynamic of antimicrobial resistance-
The dynamics of antimicrobial resistance in developing countries are poorly understood, especially in community settings, due to a sparsity of data on AMR prevalence and genetics. We used a combination of phenotyping, genomics and antimicrobial usage data to investigate patterns of AMR amongst atypical enter pathogenic Escherichia coli strains isolated from children younger than five years old in seven developing countries over a three-year period. We detected high rates of AMR, with 65% of isolates displaying resistance to three or more drug classes. Whole-genome sequencing revealed a diversity of known genetic mechanisms for AMR that accounted for >95% of phenotypic resistance, with comparable rates amongst aEPEC strains associated with diarrhoea or asymptomatic carriage. Genetic determinants of AMR were associated with the geographic location of isolates, not E. coli lineage, and AMR genes were frequently co-located, potentially enabling the acquisition of multi-drug resistance in a single step. Comparison of AMR with antimicrobial usage data showed that the prevalence of resistance to fluoroquinolones and third-generation cephalosporin’s was correlated with usage, which was higher in South Asia than in Africa. This study provides much-needed insights into the frequency and mechanisms of AMR in intestinal E. coli in children living in community settings in developing countries.

Track:15
Microbial Biochemistry:
Microbial biochemistry comprises of biochemical reactions in microbial growth, various modes and mechanisms/ processes of pathogenesis required in causing infection/ diseases in the host. It involves the study of microbial growth, microbial cell structure, microbial metabolism, primary and advanced functions and the interactions of biological macromolecules, like carbohydrates, proteins, Fatty Acids and Lipids and nucleic acids; which cater the skeletal aspect and basis of functions affiliated with life. Biochemical study of microbes is crucial in the processes of their action. Post genomic analyses, maintenance of mechanisms, & functional replication, integrating plasmid functions, conjugation systems and regulatory network are the key factors that play a vital role in metabolism of microbes. When monomers are co-linked to synthesize a polymer, dehydration occurs often resulting in assembly of different macromolecules in much larger complexes.

Track:16
Infectious diseases:
Infectious diseases are disorders caused by organisms — such as bacteria, viruses, fungi or parasites. Many organisms live in and on our bodies. They're normally harmless or even helpful, but under certain conditions, some organisms may cause disease.

Some infectious diseases can be passed from person to person. Some are transmitted by bites from insects or animals. And others are acquired by ingesting contaminated food or water or being exposed to organisms in the environment.

Signs and symptoms vary depending on the organism causing the infection, but often include fever and fatigue. Mild infections may respond to rest and home remedies, while some life-threatening infections may require hospitalization.

Many infectious diseases, such as measles and chickenpox, can be prevented by vaccines. Frequent and thorough hand-washing also helps protect you from most infectious diseases.

Track:17
Health Science:
Health science is the discipline of applied science which deals with human and animal health. There are two parts to health science: the study, research, and knowledge of health and the application of that knowledge to improve health, cure diseases, and understanding how humans and animals function.

The health sciences study all aspects of health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment of patients.

Track:18
Host Pathogen Interactions:
The host-pathogen interaction is defined as how microbes or viruses sustain themselves within host organisms on a molecular, cellular, organismal or population level. This term is most commonly used to refer to disease-causing microorganisms although they may not cause illness in all hosts. Because of this, the definition has been expanded to how known pathogens survive within their host, whether they cause disease or not.

On the molecular and cellular level, microbes can infect the host and divide rapidly, causing disease by being there and causing a homeostatic imbalance in the body, or by secreting toxins which cause symptoms to appear. Viruses can also infect the host with virulent DNA, which can affect normal cell processes protein folding, or evading the immune response.

Track:19
Medical Microbiology:
Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

VISA and Invitation letter

Issue with VISA!!
Are you planning to have a professional and delightful trip to Rome, Italy???

We believe you must be having a query regarding your VISA to Visit as a Speaker/Delegate, Tourist or Business Person to Rome, Italy. Euro Clinical Microbiology 2019 Committee will be happy to help you in all regards to plan your trip to the most historic place Rome. Here is the simplest way to know the process for your Visa Approval. Kindly register for the conference at the earliest and drops us an email at clinicalmicro2019@outlook.com and avail the official invitation letter from us and attend this event ahead with a closer step for approval of your VISA.

Register/enrol here to get an official invitation letter:  https://clinicalmicrobiology.insightconferences.com/registration.php

Processing time for VISA applications may vary depending on the office and the time of the year. Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a VISA Application Centre or online E-applications, including all supporting documents.

Microbiology Market Analysis

The latest advances in microbiology have a high impact towards industrial revolution and in medical microbiology to treat major diseases and common toxicities and also affects the foodstuff that people eat and are the source of key industrial products. Such a broad field requires a necessarily broad survey of the market opportunities and challenges that will arise in upcoming years. In the modern economic climate, your business decisions are very crucial. The 10^th International Conference on Clinical Microbiology and Infectious Diseases will give an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience. Conference Series LLC Ltd welcomes all the microbiologist, research scientists, research scholars, industrial professionals and student delegates from Microbiology and Healthcare sectors to be a part of the well-regarded Euro Clinical Microbiology 2019. This will be the best amalgamation of academia, industry and research linking every aspect of Microbiology and its related fields. It is open to all types of research processes both from academic world and business.

Global Market Research Report:

The global market of Bio-refinery technologies will grow from $466.6 billion in 2016 to $714.6 billion by 2021, with a compound annual growth rate (CAGR) of 8.9% for the period of 2016-2021.

The global market for microbiology technology, equipment, and consumables market reached $9.8 billion in revenue in 2015. The market should reach nearly $12.3 billion by 2020, increasing at a compound annual growth rate (CAGR) of 4.6% from 2015 to 2020.

The most important global single-cell proteomics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.

The business market for fertility clinics in the US should reach a value of $3.6 billion in 2017 and is expected to grow to $4.5 billion by 2022 at a compound annual growth rate (CAGR) of 4.6% for the period of 2017-2022.

Past Conference Report

Clinical Microbiology 2018

Past Reports  Gallery  

Annual Clinical Microbiology 2017

Past Reports  Gallery  

Clinical Microbiology 2017

Past Reports  Gallery  

Clinical Microbiology 2016

Past Reports  Gallery